drugset / Trial / NCT02142322

Perioperative mFOLFOX-6 in Locally Advanced Gastric Cancer

NCT02142322 ↗

Phase 2 Completed 52 enrolled Seoul National University Hospital
NaSingle-groupOpen-labelTreatment

Summary

This is a Phase II Trial of Perioperative Chemotherapy with Oxaliplatin, 5-Fluorouracil, Leucovorin(MODIFIED FOLFOX6)in Patients with Locally Advanced Operable Gastric Cancer.

Timeline

Start
2004-06
Primary completion
2011-06
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject MODIFIED FOLFOX6 Unknown 100 mg/m2 Intravenous
Subject Oxaliplatin Small molecule 100 mg/m2 Intravenous
Subject fluorouracil Small molecule 2.4 g —

Indications